Resolve Biosciences
Resolve Biosciences is a biotechnology company based in Monheim am Rhein, Germany, with a facility in San Jose, California. The company specializes in advanced spatial biology through its proprietary Molecular Cartography™ platform. This technology allows for high-resolution, multiplexed spatial analysis of molecular interactions at subcellular resolution while preserving tissue samples. The Molecular Cartography platform detects hundreds of gene transcripts simultaneously, providing unparalleled sensitivity and specificity. It is fully automated and designed to expand to include DNA, protein, and metabolomic data layers in future versions. Resolve Biosciences offers this technology through a commercial service laboratory for researchers in Europe and North America, collaborating with leading research institutions worldwide. Their primary customers include research institutions focused on oncology, neuroscience, infectious diseases, and developmental biology. The company has received significant venture capital funding, reflecting strong investor confidence in the demand for spatial biology solutions.
Work at Resolve Biosciences in HR or recruiting? Claim this page
Headcount trend
Resolve Biosciences went from 15 employees in Jul 2023 to 10 in Jun 2025. Jan to Jun 2025: 0 people joined, 9 left.
Headcount data through Jun 2025
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Oct 2022 | Series B | $71M | 5 | |
| Dec 2020 | Series A | $24M | 3 |
Org structure
Headcount by department
Peer reviews
Worked with someone at Resolve Biosciences?
Anonymous peer reviews on OffTheRecord
Similar companies
Resolve Biosciences FAQ
How many employees does Resolve Biosciences have?
Resolve Biosciences has about 10 employees, unchanged over the 3 months to Jun 2025.
What is Resolve Biosciences's revenue per employee?
Resolve Biosciences makes about $800K in revenue per employee, based on $8M annual revenue and 10 employees.
How much funding has Resolve Biosciences raised?
Resolve Biosciences has raised $95M in total funding; its latest round was Series B in Oct 2022.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.